Portfolio company
Afynia
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops non-invasive blood tests to diagnose endometriosis for women and fertility clinics.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Endometrics
Endometrics develops non-invasive diagnostic tests using menstrual blood samples and genomic biomarkers to detect endometriosis for women and healthcare providers.
Genie
This company develops non-invasive diagnostics using menstrual blood to study uterine molecular biomarkers for patients experiencing infertility.
Endogene.Bio
This company develops a biological data platform using menstrual blood to provide diagnostics and patient stratification tools for pharmaceutical firms and healthcare providers.
Scanvio Medical
This company develops AI-guided ultrasound software to help gynecologists and medical centers diagnose endometriosis through real-time image analysis during standard pelvic examinations.
Freya Biosciences
This company develops microbial immunotherapies targeting the vaginal microbiome to treat infertility and other reproductive health conditions for women.
Samphire Neuroscience
This company develops a neurostimulation headband providing non-invasive brain stimulation to manage menstrual pain and mood symptoms for women and individuals with periods.
Khyria
This company develops a digital health platform providing personalised wellness insights and toolkits for women managing midlife health and menopause.
AOA Diagnostics
This biotech company develops AI-enabled liquid biopsy blood tests to detect early-stage ovarian cancer in symptomatic women.
